散开
发表于 2025-3-25 04:23:23
Development of Nanoparticles as a Vaccine Platform. In recent years, due to climate and environmental changes, inoculation against various infectious diseases has become increasingly important. When purified proteins or peptides are used as an antigen for inoculation, the effectiveness of the vaccination is often insufficient. To strengthen the imm
灰姑娘
发表于 2025-3-25 08:25:09
http://reply.papertrans.cn/67/6609/660861/660861_22.png
裙带关系
发表于 2025-3-25 14:31:24
http://reply.papertrans.cn/67/6609/660861/660861_23.png
异常
发表于 2025-3-25 19:02:12
Bioanalysishttp://image.papertrans.cn/n/image/660861.jpg
腐败
发表于 2025-3-25 21:35:55
https://doi.org/10.1007/978-3-030-78338-9multifunction nanoparticles in medicine; cancer nanotechnology; nanoparticle cancer treatment; nanomedi
Acclaim
发表于 2025-3-26 00:51:53
http://reply.papertrans.cn/67/6609/660861/660861_26.png
倒转
发表于 2025-3-26 07:01:55
Nanoparticle-Mediated Immunotherapy978-3-030-78338-9Series ISSN 2364-1118 Series E-ISSN 2364-1126
伤心
发表于 2025-3-26 10:02:28
2364-1118 ls, and systems design.Focuses on clinical potential and tra.This book is intended to serve as an authoritative reference source for a broad audience involved in the research, teaching, learning, and practice of nanotechnology in immunotherapy. The combination of nanotechnology and immunotherapy is
文字
发表于 2025-3-26 12:47:48
Multifunctional Gold Nanostars for Sensitive Detection, Photothermal Treatment and Immunotherapy of i-cancer immune response, “Cancer Vaccine” effect, to prevent cancer recurrence. Therefore, the biocompatible GNS nanoparticles have the promise for future clinical translation to improve brain cancer diagnostics and therapeutics.
孤僻
发表于 2025-3-26 17:18:44
Immunotherapy: From Discovery to Bedsides for new treatments in the immune-oncology space. Herein we review the broad categories of immunotherapy, as well as discuss the pathway(s) for bringing promising treatments to the clinic. Challenges posed by immune-oncology therapies have led to shifts in approaches to clinical trials and we will discuss these as well.